home · filing · 0001193125-23-266758
8-K
filed October 31, 2023, 7:59 PM ET
CIK 0001923840
leadership
confidence high
sentiment neutral
materiality 0.60
Third Harmonic Bio CFO and CSO depart; IND for THB335 on track for H1 2024
Third Harmonic Bio, Inc.
CFO Robert Ho resigns effective November 10, 2023; not due to any disagreement with the company.
CSO Adrian S. Ray transitions to Scientific Advisor effective November 1, 2023, to support THB335 IND.
Company initiated executive searches for successors for both roles.
IND application for THB335 expected to be filed in first half of 2024.
CEO cites strong cash position and potential strategic business development.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Robert Ho
Chief Financial Officer
Third Harmonic Bio, Inc.
Effective 2023-11-10
Filed October 31, 2023, 7:59 PM ET
received notice from Robert Ho of his intention to resign as the Company’s Chief Financial Officer, effective November 10, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert Ho resigned as Chief Financial Officer at Third Harmonic Bio, Inc..
Action resigned
Role Chief Financial Officer
Exact text from the filing
received notice from Robert Ho of his intention to resign as the Company’s Chief Financial Officer, effective November 10, 2023.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-23-266758
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.